[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Insulin Pen Industry Research Report 2024

April 2024 | 120 pages | ID: ID0FCB3B89A9EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.

Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.

According to APO Research, the global Insulin Pen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

EU is the largest Insulin Pen market with about 48% market share. Asia is follower, accounting for about 27% market share.

The key players are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee etc. Top 3 companies occupied about 69% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Pen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Pen.

The report will help the Insulin Pen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Insulin Pen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Pen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • BD
  • Ypsomed Holding
  • Dongbao
  • Owen Mumford
  • Ganlee
Insulin Pen segment by Type
  • Reusable Insulin Pen
  • Disposable Insulin Pen
Insulin Pen segment by Application
  • Hospitals
  • Clinics
  • The Chemist's Shops
Insulin Pen Segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Pen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Pen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Pen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Insulin Pen manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Insulin Pen by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Insulin Pen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

Chapter 11: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Global Market Growth Prospects
  2.2.1 Global Insulin Pen Market Size (2019-2030) & (US$ Million)
  2.2.2 Global Insulin Pen Sales (2019-2030)
  2.2.3 Global Insulin Pen Market Average Price (2019-2030)
2.3 Insulin Pen by Type
  2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
  2.3.2 Reusable Insulin Pen
  2.3.3 Disposable Insulin Pen
2.4 Insulin Pen by Application
  2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
  2.4.2 Hospitals
  2.4.3 Clinics
  2.4.4 The Chemist's Shops

3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS

3.1 Global Insulin Pen Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Insulin Pen Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Insulin Pen Revenue of Manufacturers (2019-2024)
3.4 Global Insulin Pen Average Price by Manufacturers (2019-2024)
3.5 Global Insulin Pen Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Insulin Pen, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Insulin Pen, Product Type & Application
3.8 Global Manufacturers of Insulin Pen, Date of Enter into This Industry
3.9 Global Insulin Pen Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition

4 MANUFACTURERS PROFILED

4.1 Novo Nordisk
  4.1.1 Novo Nordisk Company Information
  4.1.2 Novo Nordisk Business Overview
  4.1.3 Novo Nordisk Insulin Pen Sales, Revenue and Gross Margin (2019-2024)
  4.1.4 Novo Nordisk Insulin Pen Product Portfolio
  4.1.5 Novo Nordisk Recent Developments
4.2 Eli Lilly
  4.2.1 Eli Lilly Company Information
  4.2.2 Eli Lilly Business Overview
  4.2.3 Eli Lilly Insulin Pen Sales, Revenue and Gross Margin (2019-2024)
  4.2.4 Eli Lilly Insulin Pen Product Portfolio
  4.2.5 Eli Lilly Recent Developments
4.3 Sanofi
  4.3.1 Sanofi Company Information
  4.3.2 Sanofi Business Overview
  4.3.3 Sanofi Insulin Pen Sales, Revenue and Gross Margin (2019-2024)
  4.3.4 Sanofi Insulin Pen Product Portfolio
  4.3.5 Sanofi Recent Developments
4.4 BD
  4.4.1 BD Company Information
  4.4.2 BD Business Overview
  4.4.3 BD Insulin Pen Sales, Revenue and Gross Margin (2019-2024)
  4.4.4 BD Insulin Pen Product Portfolio
  4.4.5 BD Recent Developments
4.5 Ypsomed Holding
  4.5.1 Ypsomed Holding Company Information
  4.5.2 Ypsomed Holding Business Overview
  4.5.3 Ypsomed Holding Insulin Pen Sales, Revenue and Gross Margin (2019-2024)
  4.5.4 Ypsomed Holding Insulin Pen Product Portfolio
  4.5.5 Ypsomed Holding Recent Developments
4.6 Dongbao
  4.6.1 Dongbao Company Information
  4.6.2 Dongbao Business Overview
  4.6.3 Dongbao Insulin Pen Sales, Revenue and Gross Margin (2019-2024)
  4.6.4 Dongbao Insulin Pen Product Portfolio
  4.6.5 Dongbao Recent Developments
4.7 Owen Mumford
  4.7.1 Owen Mumford Company Information
  4.7.2 Owen Mumford Business Overview
  4.7.3 Owen Mumford Insulin Pen Sales, Revenue and Gross Margin (2019-2024)
  4.7.4 Owen Mumford Insulin Pen Product Portfolio
  4.7.5 Owen Mumford Recent Developments
4.8 Ganlee
  4.8.1 Ganlee Company Information
  4.8.2 Ganlee Business Overview
  4.8.3 Ganlee Insulin Pen Sales, Revenue and Gross Margin (2019-2024)
  4.8.4 Ganlee Insulin Pen Product Portfolio
  4.8.5 Ganlee Recent Developments

5 GLOBAL INSULIN PEN MARKET SCENARIO BY REGION

5.1 Global Insulin Pen Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Insulin Pen Sales by Region: 2019-2030
  5.2.1 Global Insulin Pen Sales by Region: 2019-2024
  5.2.2 Global Insulin Pen Sales by Region: 2025-2030
5.3 Global Insulin Pen Revenue by Region: 2019-2030
  5.3.1 Global Insulin Pen Revenue by Region: 2019-2024
  5.3.2 Global Insulin Pen Revenue by Region: 2025-2030
5.4 North America Insulin Pen Market Facts & Figures by Country
  5.4.1 North America Insulin Pen Market Size by Country: 2019 VS 2023 VS 2030
  5.4.2 North America Insulin Pen Sales by Country (2019-2030)
  5.4.3 North America Insulin Pen Revenue by Country (2019-2030)
  5.4.4 U.S.
  5.4.5 Canada
5.5 Europe Insulin Pen Market Facts & Figures by Country
  5.5.1 Europe Insulin Pen Market Size by Country: 2019 VS 2023 VS 2030
  5.5.2 Europe Insulin Pen Sales by Country (2019-2030)
  5.5.3 Europe Insulin Pen Revenue by Country (2019-2030)
  5.5.4 Germany
  5.5.5 France
  5.5.6 U.K.
  5.5.7 Italy
  5.5.8 Russia
5.6 Asia Pacific Insulin Pen Market Facts & Figures by Country
  5.6.1 Asia Pacific Insulin Pen Market Size by Country: 2019 VS 2023 VS 2030
  5.6.2 Asia Pacific Insulin Pen Sales by Country (2019-2030)
  5.6.3 Asia Pacific Insulin Pen Revenue by Country (2019-2030)
  5.6.4 China
  5.6.5 Japan
  5.6.6 South Korea
  5.6.7 India
  5.6.8 Australia
  5.6.9 China Taiwan
  5.6.10 Indonesia
  5.6.11 Thailand
  5.6.12 Malaysia
5.7 Latin America Insulin Pen Market Facts & Figures by Country
  5.7.1 Latin America Insulin Pen Market Size by Country: 2019 VS 2023 VS 2030
  5.7.2 Latin America Insulin Pen Sales by Country (2019-2030)
  5.7.3 Latin America Insulin Pen Revenue by Country (2019-2030)
  5.7.4 Mexico
  5.7.5 Brazil
  5.7.6 Argentina
5.8 Middle East and Africa Insulin Pen Market Facts & Figures by Country
  5.8.1 Middle East and Africa Insulin Pen Market Size by Country: 2019 VS 2023 VS 2030
  5.8.2 Middle East and Africa Insulin Pen Sales by Country (2019-2030)
  5.8.3 Middle East and Africa Insulin Pen Revenue by Country (2019-2030)
  5.8.4 Turkey
  5.8.5 Saudi Arabia
  5.8.6 UAE

6 SEGMENT BY TYPE

6.1 Global Insulin Pen Sales by Type (2019-2030)
  6.1.1 Global Insulin Pen Sales by Type (2019-2030) & (K Units)
  6.1.2 Global Insulin Pen Sales Market Share by Type (2019-2030)
6.2 Global Insulin Pen Revenue by Type (2019-2030)
  6.2.1 Global Insulin Pen Sales by Type (2019-2030) & (US$ Million)
  6.2.2 Global Insulin Pen Revenue Market Share by Type (2019-2030)
6.3 Global Insulin Pen Price by Type (2019-2030)

7 SEGMENT BY APPLICATION

7.1 Global Insulin Pen Sales by Application (2019-2030)
  7.1.1 Global Insulin Pen Sales by Application (2019-2030) & (K Units)
  7.1.2 Global Insulin Pen Sales Market Share by Application (2019-2030)
7.2 Global Insulin Pen Revenue by Application (2019-2030)
  7.2.1 Global Insulin Pen Sales by Application (2019-2030) & (US$ Million)
  7.2.2 Global Insulin Pen Revenue Market Share by Application (2019-2030)
7.3 Global Insulin Pen Price by Application (2019-2030)

8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET

8.1 Insulin Pen Value Chain Analysis
  8.1.1 Insulin Pen Key Raw Materials
  8.1.2 Raw Materials Key Suppliers
  8.1.3 Insulin Pen Production Mode & Process
8.2 Insulin Pen Sales Channels Analysis
  8.2.1 Direct Comparison with Distribution Share
  8.2.2 Insulin Pen Distributors
  8.2.3 Insulin Pen Customers

9 GLOBAL INSULIN PEN ANALYZING MARKET DYNAMICS

9.1 Insulin Pen Industry Trends
9.2 Insulin Pen Industry Drivers
9.3 Insulin Pen Industry Opportunities and Challenges
9.4 Insulin Pen Industry Restraints

10 REPORT CONCLUSION

11 DISCLAIMER



More Publications